STOCK TITAN

[144] EXELIXIS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the planned sale of 99,574 Common shares with an aggregate value of $4,382,506.87 on 02/18/2026. The notice lists prior issuances and exercises of Common stock on several dates, including 03/29/2021, 04/01/2019, 05/21/2021, 05/23/2020, and 04/04/2022.

Positive

  • None.

Negative

  • None.

Insights

Form 144 filed for resale of $4.38M in Common stock by an intermediary.

The filing lists a proposed sale of 99,574 Common shares with an aggregate value of $4,382,506.87 dated 02/18/2026. It identifies Morgan Stanley Smith Barney LLC as the broker-dealer handling the transaction.

Timing and execution details are not included in the excerpt; the sale is a notice of intent under resale rules. Subsequent transaction reporting and settlement details will appear in future filings when the sale is executed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.47B
253.13M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA